Direkt zum Inhalt
Merck
  • Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.

Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2014-07-11)
Sarah Y Branch, Ramaswamy Sharma, Michael J Beckstead
ZUSAMMENFASSUNG

Substantia nigra dopamine neurons are involved in behavioral processes that include cognition, reward learning, and voluntary movement. Selective deterioration of these neurons is responsible for the motor deficits associated with Parkinson's disease (PD). Aging is the leading risk factor for PD, suggesting that adaptations occurring in dopamine neurons during normal aging may predispose individuals to the development of PD. Previous studies suggest that the unique set of ion conductances that drive spontaneous, rhythmic firing of action potentials could predispose substantia nigra dopamine neurons to selective neurodegeneration. Here we show, using patch-clamp electrophysiological recordings in brain slices, that substantia nigra dopamine neurons from mice 25-30 months of age (old) have comparable membrane capacitance and input resistance to neurons from mice 2-7 months of age (young). However, neurons from old mice exhibit slower firing rates, narrower spike widths, and more variable interspike intervals compared with neurons from young mice. Dopamine neurons from old mice also exhibit smaller L-type calcium channel currents, providing a plausible mechanism that likely contributes to the changes in impulse activity. Age-related decrements in the physiological function of dopamine neurons could contribute to the decrease in voluntary movement and other dopamine-mediated behaviors observed in aging populations. Furthermore, as pharmacological antagonism of L-type calcium channels has been proposed as a potential treatment for the early stages of PD, our results could point to a limited temporal window of opportunity for this therapeutic intervention.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Cäsiumchlorid, ReagentPlus®, 99.9%
Sigma-Aldrich
2,2,2-Tribromethanol, 97%
Sigma-Aldrich
Ethylenglykol-bis(2-aminoethylether)-N,N,N′,N′-Tetraessigsäure, Molecular Biology, ≥97.0%
Sigma-Aldrich
Cäsiumchlorid, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, 99.9%
Sigma-Aldrich
Adenosin, ≥99%
Sigma-Aldrich
Kynurensäure, ≥98%
Sigma-Aldrich
Cäsiumchlorid, Molecular Biology, ≥98%
Sigma-Aldrich
Cadmiumchlorid, 99.99% trace metals basis
Sigma-Aldrich
Ethylenglykol-bis(2-aminoethylether)-N,N,N′,N′-Tetraessigsäure, ≥97.0%
Sigma-Aldrich
Guanosin, ≥98%
Sigma-Aldrich
Cäsiumchlorid, ≥99.999% trace metals basis
Sigma-Aldrich
Picrotoxin, powder
Sigma-Aldrich
Adenosin, BioReagent, suitable for cell culture
Sigma-Aldrich
Cäsiumchlorid, Molecular Biology, ≥99% (silver nitrate titration)
Sigma-Aldrich
Ethylenglykol-bis(2-aminoethylether)-N,N,N′,N′-Tetraessigsäure, BioUltra, ≥99.0% (T)
Sigma-Aldrich
Cadmiumchlorid
Sigma-Aldrich
Guanosin, BioReagent, suitable for cell culture
Sigma-Aldrich
Cäsiumchlorid, Grade I, ≥99.0%
Sigma-Aldrich
Apamin, from bee venom, ≥95% (HPLC)
Sigma-Aldrich
Adenosin
Sigma-Aldrich
Cäsiumchlorid, 99.99% trace metals basis
Sigma-Aldrich
Cäsiumchlorid, optical grade, ≥99.5% trace metals basis
Sigma-Aldrich
DNQX, ≥98% (TLC)
Sigma-Aldrich
Ethylenglykol-bis(2-aminoethylether)-N,N,N′,N′-Tetraessigsäure, BioXtra, ≥97 .0%
Sigma-Aldrich
Cäsiumchlorid, puriss. p.a., ≥99.5%
Sigma-Aldrich
Cäsiumchlorid, BioUltra, Molecular Biology, ≥99.5% (AT)
Supelco
Adenosin, Pharmaceutical Secondary Standard; Certified Reference Material
Tyrosin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Nimodipin
Sigma-Aldrich
Hexamethoniumchlorid, solid (hygroscopic)